Faculty

Back to Index
Kevin Nash, PhD
Associate Professor of Clinical Pathology
Pathology
HMR 209 Health Sciences Campus Los Angeles
+1 323 442 1295

Publications

Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash K, Parodi N, Strong A, Gee M, Smith T, Wallace RJ. Erratum for Brown-Elliott et al. , Utility of Sequencing the erm(41) Gene in Isolates of Mycobacterium abscessus subsp. abscessus with Low and Intermediate Clarithromycin MICs. J Clin Microbiol. 2016 Apr; 54(4):1172. View in: PubMed

Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash K, Parodi N, Strong A, Gee M, Smith T, Wallace RJ. Utility of Sequencing the erm(41) Gene in Isolates of Mycobacterium abscessus subsp. abscessus with Low and Intermediate Clarithromycin MICs. J Clin Microbiol. 2015 Apr; 53(4):1211-5. View in: PubMed

Brown-Elliott BA, Hanson K, Vasireddy S, Iakhiaeva E, Nash KA, Vasireddy R, Parodi N, Smith T, Gee M, Strong A, Barker A, Cohen S, Muir H, Slechta ES, Wallace RJ. Absence of a Functional erm Gene in Isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum Group, Based on In Vitro Clarithromycin Susceptibility. J Clin Microbiol. 2015 Mar; 53(3):875-8. View in: PubMed

Geary LA, Nash KA, Adisetiyo H, Liang M, Liao CP, Jeong JH, Zandi E, Roy-Burman P. CAF-Secreted Annexin A1 Induces Prostate Cancer Cells to Gain Stem Cell-like Features. Mol Cancer Res. 2014 Apr; 12(4):607-21. View in: PubMed

Brown-Elliott BA, Nash KA, Wallace RJ. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012 Jul; 25(3):545-82. View in: PubMed

Andini N, Nash KA. Expression of tmRNA in mycobacteria is increased by antimicrobial agents that target the ribosome. FEMS Microbiol Lett. 2011 Sep; 322(2):172-9. View in: PubMed

Nash KA, Brown-Elliott BA, Wallace RJ. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009 Apr; 53(4):1367-76. View in: PubMed

Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace RJ. Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother. 2006 Oct; 50(10):3476-8. View in: PubMed

Andini N, Nash KA. Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. Antimicrob Agents Chemother. 2006 Jul; 50(7):2560-2. View in: PubMed

Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother. 2005 Feb; 55(2):170-7. View in: PubMed

Ohkusu K, Bermudez LE, Nash KA, MacGregor RR, Inderlied CB. Differential virulence of Mycobacterium avium strains isolated from HIV-infected patients with disseminated M. avium complex disease. J Infect Dis. 2004 Oct 1; 190(7):1347-54. View in: PubMed

Nash KA. Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). Antimicrob Agents Chemother. 2003 Oct; 47(10):3053-60. View in: PubMed

Nash KA. Effect of drug concentration on emergence of macrolide resistance in Mycobacterium avium. Antimicrob Agents Chemother. 2001 Jun; 45(6):1607-14. View in: PubMed

Powered bySC CTSI